Status:
COMPLETED
Determination of Amifostine Levels During Radiation Therapy
Lead Sponsor:
University of Iowa
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Currently, there are no published methods for easily determining the level of amifostine in the blood or saliva. A method has been developed within the Department of Radiation Oncology by Drs. Douglas...
Detailed Description
Currently, there are no published methods for easily determining the level of amifostine in the blood or saliva. A method has been developed within the Department of Radiation Oncology by Drs. Douglas...
Eligibility Criteria
Inclusion
- Ability to understand and willingness to sign a written informed consent document.
- Receiving radiation treatment at University of Iowa Hospitals and Clinics.
- Voluntarily elected to receive amifostine during treatment
Exclusion
- none
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00286611
Start Date
October 1 2004
End Date
May 1 2008
Last Update
June 10 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Department of Radiation Oncology
Iowa City, Iowa, United States, 52242